Clinical Trial Update: A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

View source ↗

Summary

A Japanese trial assessing safety and effectiveness of combining darolutamide with androgen deprivation therapy and docetaxel in routine medical care for men wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Low-volume Metastatic Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• DOCETAXEL (DOCETAXEL)
• Darolutamide (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Low-volume Metastasis | Status: RECRUITING